Nuance Concentrated Value Fund Investor Class NCAVX

Morningstar Medalist Rating
  • NAV / 1-Day Return$14.58  /  −0.55%
  • Fund Size$39.0M
  • Adjusted Expense Ratio1.300%
  • Net Expense Ratio1.280%
  • Fee Level: DistributionHigh
  • Share Class TypeFront Load
  • Morningstar CategoryMid-Cap Value
  • Equity Style Box (Funds)Mid Value
  • Minimum Initial Investment$2,500
  • Investment StatusOpen
  • TTM Yield1.34%
  • Turnover Ratio114%

Morningstar’s Analysis NCAVX

Will NCAVX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Nuance Concentrated Value Investor holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings NCAVX

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings62.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Beiersdorf AG ADR

11.755M
Consumer Defensive

Qiagen NV

11.135M
Healthcare

Clorox Co

10.334M
Consumer Defensive

First American Government Obligs X

8.734M
Cash and Equivalents

California Water Service Group

5.772M
Utilities

Kimberly-Clark Corp

5.282M
Consumer Defensive

Henkel AG & Co KGaA ADR

4.832M
Consumer Defensive

Kenvue Inc

4.802M
Consumer Defensive

Solventum Corp

3.041M
Healthcare

Lindsay Corp

2.721M
Industrials

Sponsor Center